• top_image


Please see our news in the archive to the right.

Metformin may increase ovarian cancer survival

December 21, 2012

A retrospective, case-control study at Mayo Clinic, found the diabetes drug metformin may increase survival in women with ovarian cancer. It reported that ovarian cancer patients with diabetes taking metformin during treatment had a 4 times greater 5-year survival rate, compared to non-diabetic ovarian cancer patients not taking the drug. <link href="http://www.ncbi.nlm.nih.gov/pubmed/22183212">Abstract here</link>.

Supreme Court to hear case against BRCA1 & BRCA2 patents

December 5, 2012

The Supreme Court will hear arguments challenging the patents of 2 genes associated with breast and ovarian cancer - the BRCA1 and BRCA2 genetic mutations, which are currently owned by Myriad Laboratories. The lawsuit charges the patents stifle diagnostic testing and research that could lead to cures and limit a woman’s medical options. The Alliance has joined the suit; the ACLU and Public Patent Foundation first filed it in 2009.